Image

COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)

COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to learn whether different ways of providing information and follow-up support after acute kidney injury, also called AKI, can improve care transitions for adults being discharged from the hospital. AKI is a sudden decrease in kidney function that can occur during a hospital stay.

The main questions this study aims to answer are:

  • Does an AKI discharge summary template improve communication about AKI after hospital discharge?
  • Does a chat-based educational messaging program improve patient understanding of AKI and support follow-up care after hospital discharge?
  • Researchers will compare usual care, an AKI discharge summary template, a chat-based educational messaging program, and the combination of the discharge summary template plus chat-based messaging.

Researchers will compare four groups:

  • Usual care
  • An AKI discharge summary template
  • A chat-based educational messaging program
  • Both the AKI discharge summary template and the chat-based educational messaging program

Participants will complete questionnaires at the start of the study and about 4 weeks after hospital discharge. Participants will also receive a brief phone call about 3 months after discharge, and the research team will review their medical record for information about follow-up care, lab testing, emergency department visits, and hospital readmissions.

Description

Acute kidney injury, also called AKI, is a common complication during hospitalization and is associated with increased risk of poor outcomes after discharge, including incomplete kidney recovery, medication-related safety concerns, emergency department visits, and hospital readmissions. Despite these risks, information about AKI and recommended follow-up care may not always be communicated clearly to patients or outpatient clinicians during the transition from hospital to home.

This pilot randomized clinical trial will evaluate the feasibility and preliminary effects of two care transition strategies for adults hospitalized with AKI. The strategies include an AKI discharge summary template designed to improve communication with outpatient clinicians, and a chat-based educational messaging program designed to provide patients with AKI-related information after discharge.

Participants will be assigned to one of four study groups: usual care, the AKI discharge summary template, the chat-based educational messaging program, or both the discharge summary template and chat-based messaging. The study will assess whether these strategies are feasible to deliver and acceptable to participants, and whether they improve patient knowledge, perceived preparedness, communication about AKI, and completion of recommended follow-up care after hospital discharge.

Participants will complete study questionnaires and allow the research team to review their medical records for information related to kidney function monitoring, follow-up care, emergency department visits, and hospital readmissions. The results of this pilot study will help inform the design of a larger future trial to improve care transitions for patients recovering from AKI.

Eligibility

Inclusion Criteria:

  • Age 18 years or older
  • Hospitalized with Stage 2 or Stage 3 acute kidney injury
  • Kidney function has not returned to baseline at the time of hospital discharge
  • Able to communicate in English
  • Able to provide informed consent
  • Willing and able to participate in study procedures independently or with assistance from a patient-designated care partner

Exclusion Criteria:

  • Acute kidney injury requiring ongoing dialysis at the time of hospital discharge
  • End-stage kidney disease
  • Kidney transplant recipient
  • Currently pregnant
  • Documented cognitive impairment that precludes informed consent
  • Receiving hospice or comfort-focused end-of-life care

Study details
    Acute Kidney Injury
    Acute Kidney Injury (AKI)

NCT07626268

Northwell Health

21 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.